Monday, August 15, 2022
HomeAddiction ResearchNo evidence that electronic nicotine delivery helps smokers quit

No evidence that electronic nicotine delivery helps smokers quit

Researchers at Georgia State University in the United States found no evidence that use of electronic nicotine delivery systems, within context of the 2015-16 US regulatory and tobacco and vaping market landscape, helped adult smokers quit at rates higher than smokers who did not use these products.

The researchers in the university’s School of Public Health published an article in PlosOne journal this month titled “Are electronic nicotine delivery systems helping cigarette smokers quit? Evidence from a prospective cohort study of US adult smokers, 2015-2016”.

The authors are Scott R. Weaver, Jidong Huang, Terry F. Pechacek, John Wesley Heath, David L. Ashley and Michael P Eriksen

Abstract

The potential of electronic nicotine delivery systems (ENDS) to reduce the cardiovascular and other disease risks of smoking is of great interest. While many smokers report using ENDS for cessation, their impact under real-world use patterns and conditions on adult smokers’ quitting behavior is uncertain.

The objective of this study was to generate more recent and comprehensive evidence on the effect of “real world” ENDS use on the population quit rates of adult smokers while taking account of frequency and duration of use, device type, e-liquid flavor, and reasons for use.

Methods and findings

We conducted a population-based, prospective cohort study of a random probability sample of 1,284 US adult smokers recruited in August/September 2015 and re-contacted one-year later (September 2016) from GfK’s KnowledgePanel, a national, probability-based web-panel designed to be representative of non-institutionalized US adults. Among the 1,081 baseline smokers who remained members of KnowledgePanel, 858 completed the follow-up survey.

The primary outcome was smoking abstinence for at least 30 days prior to follow-up. Secondary outcomes were making a quit attempt during the 12-month study period and number of cigarettes smoked per day at follow-up.

The adjusted odds of quitting smoking were lower for those that used ENDS at baseline (9.4%, 95% CI = 5.22%-16.38%; AOR = 0.30, 95% CI = 0.13–0.72) compared to smokers who did not use at ENDS (18.9%, 95% CI = 14.24%-24.68%). Smokers who used ENDS daily at some point during the study period were also less likely to quit smoking than non-users (AOR = 0.17; 95% CI = 0.04–0.82). Limited ability to draw causal inferences from the observational design and a lack of biochemical verification of quitting smoking or ENDS use are limitations of this study.

 Conclusions

We found no evidence that ENDS use, within context of the 2015-2016 US regulatory and tobacco/vaping market landscape, helped adult smokers quit at rates higher than smokers who did not use these products.

Absent any meaningful changes, ENDS use among adult smokers is unlikely to be a sufficient solution to obtaining a meaningful increase in population quit rates. Additional research is needed to reconcile the divergent literature and monitor the impact of ENDS in an environment of rapidly evolving markets and regulatory policies.

[link url="http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0198047"]Full article in PlosOne[/link]

Subscribe to our Newsletter

Receive Medical Brief's free weekly e-newsletter.

* indicates required